FDA Approved: OXTELLAR XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OXTELLAR XR (oxcarbazepine) from Supernus Pharmaceuticals, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• OXTELLAR XR (oxcarbazepine)

Snippet

SUPPL AP for OXTELLAR XR (OXCARBAZEPINE)